Search Count: 19
 |
Pi3Ka H1047R Co-Crystal Structure With Inhibitor In Cryptic Pocket Near H1047R (Compound 4).
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.58 Å Release Date: 2024-03-20 Classification: SIGNALING PROTEIN Ligands: YO4, YNZ |
 |
Pi3Ka H1047R Co-Crystal Structure With Inhibitor In Cryptic Pocket (Compound 5).
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.20 Å Release Date: 2024-03-20 Classification: SIGNALING PROTEIN Ligands: YOR, YNZ, CL |
 |
Pi3Ka H1047R Co-Crystal Structure With Inhibitors In Two Cryptic Pockets (Compounds 4 And 5).
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.35 Å Release Date: 2024-03-20 Classification: SIGNALING PROTEIN Ligands: YO4, YOR, YNZ |
 |
Pi3Ka H1047R Co-Crystal Structure With Inhibitor In Cryptic Pocket Near H1047R (Compound 12).
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.93 Å Release Date: 2024-03-20 Classification: SIGNALING PROTEIN Ligands: 1LT, YQB |
 |
Pi3Ka H1047R Co-Crystal Structure With Inhibitor In Cryptic Pocket Near H1047R (Compound 7).
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.61 Å Release Date: 2024-03-20 Classification: SIGNALING PROTEIN Ligands: YQ2, 1LT |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2022-11-09 Classification: GENE REGULATION Ligands: 9JL, FMT |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2022-11-09 Classification: GENE REGULATION |
 |
Crystal Structure Of Sos1 With Mrtx0902, A Potent And Selective Inhibitor Of The Sos1:Kras Protein-Protein Interaction
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2022-07-27 Classification: SIGNALING PROTEIN/INHIBITOR Ligands: NKF |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.29 Å Release Date: 2022-07-27 Classification: SIGNALING PROTEIN/INHIBITOR Ligands: NL0 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2022-03-16 Classification: TRANSFERASE/INHIBITOR Ligands: SFG |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.01 Å Release Date: 2022-01-26 Classification: TRANSFERASE Ligands: CL, NA, EDO, 81X, MTA |
 |
Prmt5/Mep50 Crystal Structure With Mta And A Phthalazinone Inhibitor Bound (Compound 9)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.78 Å Release Date: 2022-01-26 Classification: TRANSFERASE/INHIBITOR Ligands: MTA, 84W |
 |
Prmt5/Mep50 Crystal Structure With Mta And A Phthalazinone Inhibitor Bound (Compound (M)-31)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2022-01-26 Classification: TRANSFERASE/INHIBITOR Ligands: MTA, 85E |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.62 Å Release Date: 2022-01-26 Classification: TRANSFERASE/INHIBITOR Ligands: MTA, 85K |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.14 Å Release Date: 2022-01-26 Classification: TRANSFERASE/INHIBITOR Ligands: 97L, MTA |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2022-01-26 Classification: TRANSFERASE/INHIBITOR Ligands: 97X, MTA |
 |
Identification Of The Clinical Development Candidate Mrtx849, A Covalent Krasg12C Inhibitor For The Treatment Of Cancer
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.27 Å Release Date: 2020-04-22 Classification: HYDROLASE/INHIBITOR Ligands: GDP, MG, M1R |
 |
Identification Of The Clinical Development Candidate Mrtx849, A Covalent Krasg12C Inhibitor For The Treatment Of Cancer
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.03 Å Release Date: 2020-04-22 Classification: HYDROLASE/INHIBITOR Ligands: GDP, MG, QH4 |
 |
Identification Of The Clinical Development Candidate Mrtx849, A Covalent Krasg12C Inhibitor For The Treatment Of Cancer
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2020-04-22 Classification: HYDROLASE/INHIBITOR Ligands: GDP, MG, M1X |